Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort
African Health Sciences · 15.04.2026 · 26 (1) · 104-114
DOI: 10.4314/ahs.v26i1.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Health Sciences, online erschienen am 15.04.2026. Verfasst von Yahia Massinissa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology's Laboratory of the Bioactive Molecules and the Cellular Physiopathology, Faculty of Biological Sciences, Department of Biology and Liv…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mutation, Proto-Oncogene Proteins p21(ras). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) ranks as the third most prevalent malignancy globally, with incidence rates rising steadily in Algeria. Prognostic assessment of CRC increasingly relies on molecular profiling, particularly mutations in the KRAS gene a critical determinant of resistance to anti-EGFR therapies in metastatic disease.
Objectives
This study investigates the KRAS mutational spectrum and its association with clinicopathological features in CRC patients from Batna, Eastern Algeria.
Methods
In a retrospective analysis of 91 cases, KRAS mutations were identified in 46.2% of tumors (wild-type: 58.3%) using RT-PCR and sequencing.
Results
The most frequent alterations localized to codons 12 and 13 (exons 1–2), with p.G12D (c.35G>A) and p.G13D (c.38G>A) predominating. Strikingly, KRAS mutation status showed no significant correlation with age, sex, tumor size, histology, metastatic pattern, or TNM stage suggesting its role as an independent molecular driver rather than a surrogate for conventional prognostic markers.
Conclusion
These findings underscore the high prevalence of KRAS mutations in Algerian CRC patients and highlight their potential utility in refining therapeutic strategies, particularly for anti-EGFR eligibility. The study provides the first regional dataset from Eastern Algeria, addressing a critical gap in North African oncogenomics. Keywords: CCR; mutated KRAS; wild-type KRAS; mutations; Algeria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology's Laboratory of the Bioactive Molecules and the Cellular Physiopathology, Faculty of Biological Sciences, Department of Biology and Living Organisms, University of Mustapha Ben Boulaid. 53 Constantine Rd,…
- Department of Molecular and Cellular Biology, University of Khenchela Abbes Laghrour. 40000.
- Laboratory of Anapathology, CHU of Batna, Algeria.
Zitieren
APA
Massinissa, Y., Benhouda, A., Khadraoui, H., Benouda, D., Khettache, W., & Soussi, A. (2026). Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort. African Health Sciences, 26(1), 104-114. https://doi.org/10.4314/ahs.v26i1.12
Vancouver
Massinissa Y, Benhouda A, Khadraoui H, Benouda D, Khettache W, Soussi A. Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort. African Health Sciences. 2026;26(1):104-114. doi:10.4314/ahs.v26i1.12
BibTeX
@article{Massinissa2026,
author = {Massinissa, Yahia and Benhouda, Afaf and Khadraoui, Hachani and Benouda, Djahida and Khettache, Wafa and Soussi, Atika},
title = {Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort},
journal = {African Health Sciences},
year = {2026},
volume = {26},
number = {1},
pages = {104--114},
doi = {10.4314/ahs.v26i1.12}
}
EUVIMED